S, N., & B, R. (2026). CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient iPSC-derived RPE Cells. Investigative ophthalmology & visual science, 67(2), 9. https://doi.org/10.1167/iovs.67.2.9
Παραπομπή σε μορφή Chicago (17η εκδ.)S, Navneet, και Rohrer B. "CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient IPSC-derived RPE Cells." Investigative Ophthalmology & Visual Science 67, no. 2 (2026): 9. https://doi.org/10.1167/iovs.67.2.9.
Παραπομπή σε μορφή MLA (9th εκδ.)S, Navneet, και Rohrer B. "CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient IPSC-derived RPE Cells." Investigative Ophthalmology & Visual Science, vol. 67, no. 2, 2026, p. 9, https://doi.org/10.1167/iovs.67.2.9.